Cameron John Reynolds - 14 Oct 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Reporting relationship: President and CEO, Director
Issuer ticker: VNRX
Reported as of: 14 Oct 2025
Net transaction value: +$57,200
SEC form: 4
Accepted by SEC: 15 Oct 2025, 16:05:45 UTC
Prior SEC filing: 15 Sep 2025
Next SEC filing: 17 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Cameron John Reynolds

Key filing fact

Cameron John Reynolds filed Form 4 for VOLITIONRX LTD (VNRX) on 15 Oct 2025.

Key facts

This page summarizes Cameron John Reynolds's Form 4 filing for VOLITIONRX LTD (VNRX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Oct 2025, 16:05.

Change

Previous filing in this sequence was filed on 15 Sep 2025.
Current net transaction value: +$57,200.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001340610 Primary reporting owner

Reynolds Cameron John

Relationship: President and CEO, Director
Address: 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON
Signature: /s/ Cameron John Reynolds
Signature date: 15 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNRX transaction

Common Stock

Purchase

Transaction value: $56,100
Shares: +110,000
Change %: +4.5%
Price: $0.5100
Shares after: 2,534,847
Date: 14 Oct 2025
Ownership: Direct
Footnotes: F1

VNRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,007,718
Date: 14 Oct 2025
Ownership: By Concord International, Inc.
Footnotes: F2

VNRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 34,076
Date: 14 Oct 2025
Ownership: By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VNRX transaction Derivative

Warrant (Right to Buy)

Purchase

Transaction value: $1,100
Shares: +110,000
Change %
Price: $0.0100^*
Shares after: 110,000
Date: 14 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 110,000
Exercise price: $0.6000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer. The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant.

Footnote F2

The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.